Kimia Farma acquires Dawaa in Mideast expansion bid
The Jakarta Post
State-owned pharmaceutical company PT Kimia Farma has announced its acquisition of Dawaa Medical Limited Company as an initial step to expanding its business in Saudi Arabia.
Under the acquisition terms, Kima Farma has taken over 60 percent of Dawaa shares worth 38 million Saudi riyal (US$10 million). The new name for the company is Kimia Farma Dawaa.
“It is an initial step to expand into Saudi Arabia with hopes of entering the African market,” Kimia Farma president director Honesty Basyir said in Jakarta on Monday, after the signing ceremony for the shares takeover agreement, kompas.com reported.
Honesty said the new acquisition in Saudi Arabia was part of its efforts to support the government’s initiative to improve healthcare services to Indonesian hajj pilgrims.
Honesty said that Al-Dawaa currently operates 31 drugstores, mostly in Mecca and Medina, and that following the acquisition, Kima Farma Dawaa would increase the number of drugstores to 90 outlets.
“We are expanding our business to Saudi Arabia because of its promising market," she added, saying that annual turnover could reach $20 billion by 2020. (bbn)
- Thousands sign petition against sentence for Malaysian who abused maid
- Saudi Arabia beheads Indonesian worker despite Jokowi’s pleas for clemency
- Bottled water meets quality standards: BPOM
- Why the rich in Jakarta have better access to water than the poor
- Missing giant yellow duck found in Australia
- No condoms or cigarettes sold at Muslim convenience store in Depok
- Anies issues regulation simplifying process of shutting down entertainment spots
- Residents clash with police personnel in land execution in C. Sulawesi
- Singapore Airlines warns customers against air tickets scam
- Indonesian short film on oil palm industry enters international festivals